Version 3.4 of the Guidelines for Inclusion of Drug Costs in Pharmacoeconomic evaluations was published 24 April 2026 and replaces version 3.3. The new version is available here.
Updates to the guidelines reflect changes following publication of the Framework Agreement on the Supply and Pricing of Medicines 2026 to 2029, and an update to the average dispensing fee cost on the Community Drugs Schemes.